Rossby Financial’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Rossby Financial's XENE Position: Q3 2026 in Review
Rossby Financial reduced its Xenon Pharmaceuticals (XENE) stake by 35% in Q3 2026, selling an estimated $3.8K and leaving 117 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.
Rossby Financial first reported a position in XENE in Q3 2025 and has held it in 5 quarters since. The position peaked at $10.9K in Q2 2026. 286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Rossby Financial held 117 shares of Xenon Pharmaceuticals worth $4.35K as of Q3 2026.
- Rossby Financial sold 64 Xenon Pharmaceuticals shares in Q3 2026, an estimated $3.8K.
- Xenon Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #1799 holding.
- Rossby Financial first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Rossby Financial's Xenon Pharmaceuticals position peaked at $10.9K in Q2 2026.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.